版权所有:内蒙古大学图书馆 技术提供:维普资讯• 智图
内蒙古自治区呼和浩特市赛罕区大学西街235号 邮编: 010021
作者机构:Hammersmith Hosp Imperial Sch Med Dept Immunol London England Hammersmith Hosp Imperial Sch Med Dept Hematol London England
出 版 物:《BLOOD》 (血液)
年 卷 期:2000年第95卷第7期
页 面:2198-2203页
核心收录:
学科分类:1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 10[医学]
主 题:抗原/免疫学 抗原 CD34/分析 印迹法 蛋白质 骨髓净化/方法 DNA结合蛋白质类/分析 DNA结合蛋白质类/免疫学 基因 肾母细胞瘤 造血干细胞/化学 造血干细胞/免疫学 造血干细胞/病理学 T淋巴细胞 细胞毒性/免疫学 转录因子/分析 转录因子/免疫学 肿瘤细胞 培养的 WT1蛋白质类 成年人 儿童 人类 男(雄)性
摘 要:Hematologic malignancies such as acute and chronic myeloid leukemia are characterized by the malignant transformation of immature CD34(+) progenitor cells. Transformation is associated with elevated expression of the Wilm s tumor gene encoded transcription factor (WT1), Here we demonstrate that WT1 can serve as a target for cytotoxic T lymphocytes (CTL) with exquisite specificity for leukemic progenitor cells. HLA-A0201-restricted CTL specific for WT1 kill leukemia cell lines and inhibit colony formation by transformed CD34(+) progenitor cells isolated from patients with chronic myeloid leukemia (CML), whereas colony formation by normal CD34(+) progenitor cells is unaffected. Thus, the tissue-specific transcription factor WT1 is an ideal target for CTL-mediated purging of leukemic progenitor cells in vitro and for antigen-specific therapy of leukemia and other WT1-expressing malignancies in vivo. (Blood. 2000;95:2198-2203) (C) 2000 by The American Society of Hematology.